UnknownNot Applicable

Pharmacological Treatment of Children and Adolescents With Severe Mood Dysregulation

Brazil20 participantsStarted 2009-01

Plain-language summary

The purpose of this study is to investigate whether Risperidone is effective in children and adolescents with severe mood dysregulation.

Who can participate

Age range7 Years – 17 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnose of Severe Mood Dysregulation * 7-17 years * IQ \> 70 Exclusion Criteria: * Bipolar disorder * IQ\<70 * Psychosis

What they're measuring

We use as the primary outcome the subscale of irritability of the Aberrant Checklist Behavior which measures the intensity of irritability, temper tantruns and hyperarousal symptoms

Timeframe: 11/2010

Trial details

NCT IDNCT00825552

SponsorFederal University of Rio Grande do Sul

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-01

View on ClinicalTrials.gov More Severe Mood Dysregulation trials